As of April 19, 2025, Cabaletta Bio (CABA) has a market cap of $55.817 million USD. According to our data, Cabaletta Bio is ranked No.7996 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $55.82 M |
-49.69%
|
Dec 31, 2024 | $0.11 B |
-90.00%
|
Dec 29, 2023 | $1.11 B |
145.41%
|
Dec 30, 2022 | $0.45 B |
144.06%
|
Dec 31, 2021 | $0.19 B |
-69.63%
|
Dec 31, 2020 | $0.61 B |
-10.67%
|
Dec 31, 2019 | $0.68 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$61.27 M |
0.051 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$36.15 M |
0.000 M
|
![]() USA
|
![]() Autolus Therapeutics
AUTL
|
$0.38 B |
0.000 M
|
![]() UK
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
Market Cap | = | CABA Stock Price | * | CABA Shares Outstanding |
= | $1.10 | * | 50.74 M | |
= | $55.82 M |